However, despite these limitations, these results must be considered as a preliminary work and further work should be conducted to evaluate and validate the role of CUBN/MPO ratio and to find the biological mechanisms underlying the relationship between CUBN and MPO in high-grade T1 bladder cancer. The gene discussed is CUBN; the disease is urinary bladder cancer.